局部维A酸类药物促进中耳黏膜再生的研究
本研究用豚鼠模型评估局部维A酸类药物对受损中耳黏膜的再生作用。结果显示再生黏膜在组织学和功能上类似正常纤毛上皮,且未观察到耳毒性;维A酸组6耳中5耳(83%)完全或部分愈合,对照组无再生(p=0.0183)。结论认为局部维A酸类药物可能是促进中耳黏膜再生且不引起耳毒性的新治疗选择,但需进一步研究后方可用于人类临床。
要点
- 局部维A酸类药物可促进豚鼠受损中耳黏膜再生。
- 再生黏膜组织学与功能类似正常纤毛上皮,未见耳毒性。
- 维A酸组83%愈合,对照组无再生,差异有统计学意义。
核心结论
- 局部维A酸类药物可能有效促进中耳黏膜再生,且不引起耳毒性。
- 尚需进一步研究后方可应用于人类临床。
研究设计与样本
- 采用豚鼠模型研究局部维A酸类药物对中耳黏膜损伤的再生作用。
- 通过组织学分析评估上皮恢复,并行听觉功能测试检测耳毒性。
主要发现
- 再生黏膜在组织学和功能上类似正常纤毛上皮。
- 给予维A酸后未观察到耳毒性。
- 维A酸组6耳中5耳(83%)完全或部分愈合,对照组无再生(p=0.0183)。
关键数值与推荐
- 维A酸组6耳中5耳(83%)完全或部分愈合,对照组无再生(p=0.0183)。
临床怎么用
- 局部维A酸类药物可能成为促进中耳黏膜再生、避免耳毒性的新型治疗选项。
- 目前仅为动物实验证据,临床应用于人类前需进一步研究。
局限性
- 研究为豚鼠模型,样本量小(维A酸组6耳),结论需进一步验证。
- 尚需进一步研究后方可应用于人类临床。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Dysfunction of the middle ear can lead to hearing loss and the development of diseases such as cholesteatoma. Although radical treatment for cholesteatoma involves complete removal of the lesion, incomplete regeneration of the middle ear mucosa may contribute to hearing loss and recurrence of the cholesteatoma. This study aimed to evaluate the regenerative potential of topical retinoid therapy for damaged middle ear mucosa. METHODS: We used a guinea pig model to investigate the regenerative effects of topical retinoids on middle ear mucosal damage. Retinoids, which are known to promote nasal mucosal epithelium regeneration, were applied to the middle ear. Histological analysis was performed to assess epithelial recovery, and auditory function testing was conducted to detect any signs of ototoxicity. RESULTS: The regenerated mucosa exhibited histological and functional characteristics comparable to those of normal ciliated epithelium. Furthermore, no ototoxicity was observed following the administration of retinoids. In the retinoid group, five of six ears (83%) demonstrated complete or partial healing, whereas none in the control group showed regeneration (p = 0.0183). The regenerated mucosa exhibited histological and functional characteristics comparable to those of normal ciliated epithelium. Furthermore, no ototoxicity was observed following the administration of retinoids. CONCLUSION: Topical retinoids may be an effective and novel therapeutic option for promoting the regeneration of middle ear mucosa without inducing ototoxic effects. Further investigations are required prior to clinical application in humans. LEVEL OF EVIDENCE: NA.
引用
- Terada S, Shinkawa C, Koizumi Y, et al. Regenerative Treatment of Middle Ear Mucosa With Topical Retinoid Administration. Laryngoscope. 2025. PMID: 41439275. doi:10.1002/lary.70322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。